Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.35% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SD
2501
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $3.52M | ﹤0.01% |
1,931,445
+141,100
| +8% | +$461K |
|
2502
Argan
AGX
$8.11B
| $3.52M | ﹤0.01% |
104,482
+506
| +0.5% | +$16.6K |
|
|
CTWS
2503
DELISTED
Connecticut Water Service Inc
CTWS
| $3.5M | ﹤0.01% |
96,459
+201
| +0.2% | +$7.07K |
|
|
DQ
2504
Daqo New Energy
DQ
$991M
| $3.5M | ﹤0.01% |
664,000
-40,170
| -6% | -$271K |
|
|
PETX
2505
DELISTED
Aratana Therapeutics, Inc.
PETX
| $3.49M | ﹤0.01% |
196,010
+63,421
| +48% | +$790K |
|
|
CCRN
2506
DELISTED
Cross Country Healthcare
CCRN
| $3.49M | ﹤0.01% |
279,587
-10,429
| -4% | -$107K |
|
|
ALDW
2507
DELISTED
Alon USA Partners LP
ALDW
| $3.49M | ﹤0.01% |
270,099
+98
| +0% | +$1.64K |
|
|
NTK
2508
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $3.48M | ﹤0.01% |
42,841
-104
| -0.2% | -$8.27K |
|
|
PRTK
2509
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.48M | ﹤0.01% |
90,326
+89,336
| +9,024% | +$2.13M |
|
2510
Altisource Portfolio Solutions
ASPS
$64.4M
| $3.47M | ﹤0.01% |
12,825
-2,780
| -18% | -$1.44M |
|
2511
Westwood Holdings Group
WHG
$186M
| $3.46M | ﹤0.01% |
55,977
-54
| -0.1% | -$3.28K |
|
|
CLMS
2512
DELISTED
Calamos Asset Management, Inc.
CLMS
| $3.46M | ﹤0.01% |
259,628
-9,599
| -4% | -$124K |
|
|
MSFG
2513
DELISTED
MainSource Financial Group Inc
MSFG
| $3.45M | ﹤0.01% |
164,955
-1,571
| -0.9% | -$28.6K |
|
|
ETP
2514
DELISTED
Energy Transfer Partners L.p.
ETP
| $3.45M | ﹤0.01% |
53,077
-474,544
| -90% | -$30.3M |
|
|
ARI
2515
Apollo Commercial Real Estate
ARI
$876M
| $3.44M | ﹤0.01% |
210,406
-2,318
| -1% | -$38K |
|
2516
Cohu
COHU
$2.81B
| $3.44M | ﹤0.01% |
288,957
-21,713
| -7% | -$247K |
|
|
AREX
2517
DELISTED
Approach Resources Inc.
AREX
| $3.43M | ﹤0.01% |
537,616
+191,029
| +55% | +$1.83M |
|
2518
Cerus
CERS
$601M
| $3.41M | ﹤0.01% |
546,910
+157,160
| +40% | +$713K |
|
2519
Customers Bancorp
CUBI
$2.82B
| $3.41M | ﹤0.01% |
175,101
-18,589
| -10% | -$344K |
|
2520
Tempest Therapeutics
TPST
$16.1M
| $3.41M | ﹤0.01% |
26
-2
| -7% | -$146K |
|
|
RDEN
2521
DELISTED
ELIZABETH ARDEN INC
RDEN
| $3.4M | ﹤0.01% |
159,025
-614,026
| -79% | -$10.9M |
|
2522
Icon
ICLR
$12.6B
| $3.4M | ﹤0.01% |
66,616
-3,514
| -5% | -$189K |
|
2523
RB Global
RBA
$15.6B
| $3.38M | ﹤0.01% |
125,781
-22,973
| -15% | -$570K |
|
|
ATSG
2524
DELISTED
Air Transport Services Group
ATSG
| $3.38M | ﹤0.01% |
394,433
-32,285
| -8% | -$257K |
|
|
AMRI
2525
DELISTED
Albany Molecular Research Inc
AMRI
| $3.38M | ﹤0.01% |
207,333
-33,277
| -14% | -$611K |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.